Express News | Aligos Therapeutics Strengthens Senior Leadership Team With the Appointment of Hardean Achneck, Md as Chief Medical Officer
Taking A Look At Haemonetics Corporation's (NYSE:HAE) ROE
Haemonetics Is Maintained at Outperform by Barrington Research
Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $108
Buy Rating Affirmed for Haemonetics With Promising Growth in Hospital Segment and Strong Plasma Market Position
Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025
Haemonetics Technology Chief to Exit
C.L. King Initiates Haemonetics(HAE.US) With Buy Rating, Announces Target Price $116
BofA Securities Initiates Haemonetics(HAE.US) With Hold Rating, Announces Target Price $85
Haemonetics Price Target Announced at $85.00/Share by B of A Securities
BTIG Initiates Haemonetics(HAE.US) With Buy Rating, Announces Target Price $112
Express News | Haemonetics Corp : Btig Initiates Coverage With Buy Rating; Price Target $112
Haemonetics: A Solid Investment in MedTech With Promising Growth and Valuation Upside
Haemonetics (NYSE:HAE) Shareholders Have Endured a 38% Loss From Investing in the Stock Five Years Ago
After Plunging -15.88% in 4 Weeks, Here's Why the Trend Might Reverse for Haemonetics (HAE)
Implied Volatility Surging for Haemonetics (HAE) Stock Options
Haemonetics Is Maintained at Neutral by Citigroup
Express News | Haemonetics Corp : Citigroup Cuts Target Price to $85 From $94
Citi Maintains Haemonetics(HAE.US) With Hold Rating, Cuts Target Price to $85
Top 3 Health Care Stocks That Are Set To Fly This Quarter